Fast Market Research announces the availability of the new TechNavio report, "Global Cell-based Assay Market 2015-2019", on their comprehensive research portal

Boston, MA -- (SBWire) -- 09/10/2015 --Cell-based assays are used to measure biochemical or cellular functions such as cell motility, morphology, cell proliferation, toxicity, and stem cell differentiation. The components of cell-based assays include instruments and consumables. These components are used for screening and analysis of the cell functionality. The ease-of-use and accuracy of measurements make them important component in various research and commercial applications such as drug discovery and toxicology.

Technavio's analysts forecast the global cell-based assay market to grow at a CAGR of 11.3% during 2014-2019.

Commenting on the report, an analyst from Technavio's team said: "For analyzing a large amount of drug samples, automation is required during cell-based assays. This process involves analyzing around tens of thousands of samples per day. Robotic automation can be applied in drug screening with some modifications of cell-based assay system such as microplate lid handling and the use of automated incubators, laminar flow hoods, and biosafety cabinets. Many research laboratories and pharmaceutical companies are taking an increased interest in using automated cell-based assay techniques in drug discovery processes, which is expected to propel market growth during the forecast period."

Get More Details on this Report and a Full Table of Contents at Global Cell-based Assay Market 2015-2019

According to the report, label-free cell-based assays analyze the target molecule without modifying it. As a result, these assays can screen complex targets. The assays are flexible for using various types of cells such as primary, mammalian, suspension, and adherent cells, propelling their adoption in the drug discovery segment. Label-free cell-based assays include GPCR, receptor panning, receptor tyrosine kinases, orphan receptor screening, and ion channels. Many consumers use these assays complementarily to the traditional assay technology.

Further, the report states that the lack technical expertise of medical professionals results in operational and technological issues, which hinders the adoption of these complex assays.

The key players in the Global Cell-based Assay Market are EMD Millipore, Perkin Elmer, Sigma-Aldrich and Life Technologies (a subsidiary of Thermo Fisher Scientific) while other prominent vendors include Agilent Technologies, Attana, BioTek Instruments, BioVision, BMG LABTECH, Cayman Chemical, Cisbio Bioassays, Corning, DiscoveRx, F. Hoffmann-La Roche, ProQinase, XENOMETRIX, Molecular Devices, Pall Corporation and Promega Corporation

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit - http://www.technavio.com/report/global-cell-based-assay-market-2015-2019

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Healthcare research reports at Fast Market Research

You may also be interested in these related reports:

-Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019
-In Vitro Diagnostics (IVD) Market - Forecast to 2020
-Global Glycated Hemoglobin Testing Market 2015-2019
-Chiral Separation Column Market - Global Forecast to 2019
-Global Departmental PACS Market - Global Forecasts to 2019